secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vor Biopharma Inc. (VOR)
CIK:        0001817229
Form:       8-K
Filed at:   2025-01-08T23:59:59+00:00
Accession:  0001193125-25-003259
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Vor Bio appoints Erez Kalir to board, filling new seat linked to Reid Hoffman-led PIPE
--------------------------------------------------------------------------------

- Board expanded from 7 to 8 members; Kalir designated by Reprogrammed Interchange (Hoffman entity).
- Kalir is co-founder & COO of Manas AI, managing member of Martial Eagle Fund, venture partner at FJ Labs.
- Standard director compensation: $40k cash retainer + option for 60k shares, plus annual 30k-share options.
- Appointment follows a December 2024 PIPE led by Reid Hoffman; Kalir serves as Class III director until 2027.
- Kalir's background includes Tiger Management, Sabretooth Capital, and a Rhodes Scholarship.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1817229/000119312525003259/0001193125-25-003259-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1817229/000119312525003259/d861124d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-003259

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer